SGEN

H.C. Wainwright Maintains Buy On Seattle Genetics On The Back Of 3Q Growth

In a research note released Friday, H.C.

Ben Mahaney, Editor — October 31, 2014, 2:27 PM EDT

H.C. Wainwright Maintains Buy On Seattle Genetics On The Heels Of Positive Data From Phase 3

In a research note published today, H.C.

Corey Williams — September 30, 2014, 2:20 PM EDT

Seattle Genetics: Positive Phase 3 AETHERA Trial Paves Path For Significant Market Potential, Says William Blair

In a research report released Monday, William Blair analyst John Sonnier maintained an Outperform rating on Seattle Genetics (NASDAQ:SGEN), following today’s news that the …

Ben Mahaney, Editor — September 29, 2014, 5:17 PM EDT

Seattle Genetics: Recent Macro Weakness Has Created A Buying Opportunity, Says H.C. Wainwright

In a research note released today, H.C.

Ben Mahaney, Editor — August 1, 2014, 3:11 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts